Press Release
TOKYO, Japan — Qoly Corporation (hereinafter “Qoly”) today announced that it has raised 1.8 billion yen in a Series A funding round. The round was led by Fast Track Initiative, Inc. (FTI) and MedVenture Partners, Inc. (MPI), with participation from Sony Group Corporation (Sony) and Development Bank of Japan Inc. (DBJ). With this capital, Qoly will launch its business operations and accelerate the development and social implementation of innovative robotic solutions designed to advance the field of microsurgery*1.
(*1) Microsurgery: A specialized surgical technique performed under a microscope to repair minute structures such as small blood vessels, nerves, and lymphatic vessels.
Surgical medicine is a critical social infrastructure, essential not only for saving lives but also for maintaining and improving the Quality of Life (QOL) for many. Microsurgery, often used to treat functional disorders, requires extremely delicate maneuvers under high magnification. Consequently, mastering these techniques demands exceptional skill and extensive experience, limiting the number of surgeons capable of performing such procedures. This shortage of specialized practitioners remains a significant barrier to the wider adoption of these life-enhancing treatments.
Qoly is dedicated to addressing these clinical challenges and enhancing patient QOL through robotics and advanced technology. The company is developing products and solutions specifically designed to assist in microsurgery. By leveraging and succeeding technologies originally developed through Sony Group’s medical robotics research, Qoly aims to accelerate the development of precise, safe, and clinically viable microsurgery-assistance robots.
About Qoly
Qoly’s mission is to “Advancing Life & QOL by Uniting Clinical Wisdom and Technology”. The company is focused on the technological development and commercialization of microsurgery-assistance robots. By succeeding a portion of the technology developed during Sony Group’s medical robotics research*2, Qoly strives to create innovative robotic solutions that evolve surgical procedures. Through the practical application of these technologies in clinical settings, Qoly aims to contribute to the realization of a sustainable healthcare system.
(*2) Prototype of the microsurgery-assistance robot announced by Sony in 2024 https://www.sony.com/ja/SonyInfo/technology/stories/entries/rd-activities/microsurgery_assistance_robot/
Company Overview
Established: October 1, 2025
Location: 3-6-4 Osaki, Shinagawa-ku, Tokyo, 141-0032, Japan
Representative: Yohei Kuroda
Capital: 909 million yen
Business: Development, manufacturing, sales, and support of microsurgery-assistance robots and related products.
Official Website: https://www.qoly.tech
